NETROMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Netromycin patents expire, and when can generic versions of Netromycin launch?
Netromycin is a drug marketed by Schering and is included in one NDA.
The generic ingredient in NETROMYCIN is netilmicin sulfate. Additional details are available on the netilmicin sulfate profile page.
Summary for NETROMYCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Patent Applications: | 634 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NETROMYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NETROMYCIN
US Patents and Regulatory Information for NETROMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | NETROMYCIN | netilmicin sulfate | INJECTABLE;INJECTION | 050544-001 | Feb 28, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | NETROMYCIN | netilmicin sulfate | INJECTABLE;INJECTION | 050544-002 | Feb 28, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | NETROMYCIN | netilmicin sulfate | INJECTABLE;INJECTION | 050544-003 | Feb 28, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |